HeartBeam Completes Enrollment Ahead of Schedule in 486-Patient Heart Attack Detection Study

• HeartBeam completed enrollment ahead of schedule in its 486-patient HEADSTART-ACS study at the National Cardiovascular Center Harapan Kita in Jakarta, Indonesia.
• The study evaluates the system’s ability to detect acute coronary syndrome, including heart attacks, against standard ECG testing and discharge diagnoses.
• Data analysis is underway, with results expected to be presented at a cardiology conference in 2027.
• The 132-patient ALIGN-ACS pilot brings combined enrollment above 600 patients; its results will be presented at TCT 2026.
• A pivotal U.S. study is planned for the first quarter of 2027; the system is not currently cleared for heart attack detection.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartbeam Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261021715503) on October 21, 2026, and is solely responsible for the information contained therein.